Keene & Associates Inc. increased its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 16.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,635 shares of the company’s stock after acquiring an additional 2,585 shares during the period. Keene & Associates Inc.’s holdings in Avanos Medical were worth $371,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Westwood Holdings Group Inc. grew its holdings in shares of Avanos Medical by 2.0% during the fourth quarter. Westwood Holdings Group Inc. now owns 2,151,091 shares of the company’s stock worth $48,249,000 after purchasing an additional 41,818 shares during the last quarter. William Blair Investment Management LLC grew its holdings in Avanos Medical by 16.8% during the 1st quarter. William Blair Investment Management LLC now owns 1,425,036 shares of the company’s stock worth $28,372,000 after acquiring an additional 204,826 shares during the last quarter. Paradice Investment Management LLC increased its position in Avanos Medical by 5.4% in the 2nd quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock valued at $26,791,000 after acquiring an additional 69,389 shares in the last quarter. Tributary Capital Management LLC increased its position in Avanos Medical by 7.5% in the 1st quarter. Tributary Capital Management LLC now owns 742,455 shares of the company’s stock valued at $14,782,000 after acquiring an additional 51,865 shares in the last quarter. Finally, Alberta Investment Management Corp raised its stake in shares of Avanos Medical by 16.6% in the fourth quarter. Alberta Investment Management Corp now owns 413,418 shares of the company’s stock worth $9,273,000 after acquiring an additional 58,826 shares during the last quarter. 95.17% of the stock is owned by institutional investors and hedge funds.
Avanos Medical Price Performance
AVNS opened at $24.00 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.49. The company’s 50 day simple moving average is $22.90 and its 200-day simple moving average is $20.67. Avanos Medical, Inc. has a one year low of $17.24 and a one year high of $24.77. The stock has a market capitalization of $1.10 billion, a P/E ratio of -18.05 and a beta of 0.91.
Avanos Medical Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Further Reading
- Five stocks we like better than Avanos Medical
- How Can Investors Benefit From After-Hours Trading
- 3 Defensive Stock Alternatives to Bonds If Interest Rates Drop
- Canada Bond Market Holiday: How to Invest and Trade
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.